This Article Full Text Full Text (PDF) Correction (v67,p8423) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Huffman, D. M. Articles by Nagy, T. R. Search for Related Content PubMed PubMed Citation Articles by Huffman, D. M. Articles by Nagy, T. R.

SIRT1 Is Significantly Elevated in Mouse and Human Prostate Cancer

Departments of ¹ Nutrition Sciences, ² Pathology, ³ Physiology and Biophysics, and ⁴ Genetics, University of Alabama at Birmingham; ⁵ Geriatric Research, Education, and Clinical Center, Veterans Affairs Medical Center, Birmingham, Alabama

Requests for reprints: Derek M. Huffman, Division of Physiology and Metabolism, Department of Nutrition Sciences, University of Alabama at Birmingham, GOO5 Volker Hall, 1670 University Boulevard, Birmingham, AL 35294-3360. Phone: 205-934-4008; Fax: 205-934-7050; E-mail: dhuffman{at}uab.edu.

Evidence suggests that the histone deacetylase, SIRT1, is a mediator of life span extension by calorie restriction; however, SIRT1 may paradoxically increase the risk of cancer. To better understand the relationship among SIRT1, energy balance, and cancer, two experiments were done. First, a transgenic mouse model of prostate cancer (transgenic adenocarcinoma of mouse prostate; TRAMP) was used to determine the role of energy balance on SIRT1 expression and the effect of cancer stage on SIRT1 and hypermethylated in cancer-1 (HIC-1). Second, immunohistochemistry was done on human prostate tumors to determine if SIRT1 was differentially expressed in tumor cells versus uninvolved cells. Results show that SIRT1 is not increased in the dorsolateral prostate (DLP) of calorie-restricted mice during carcinogenesis. In contrast, when examined in the DLP as a function of pathologic score, SIRT1 was significantly elevated in mice with poorly differentiated adenocarcinomas compared with those with less-advanced disease. HIC-1, which has been shown to regulate SIRT1 levels, was markedly reduced in the same tumors, suggesting that a reduction in HIC-1 may be in part responsible for the increased expression of SIRT1 in prostatic adenocarcinomas. Furthermore, immunostaining of human prostate tumors showed that cancer cells had greater SIRT1 expression than uninvolved cells. In conclusion, DLP SIRT1 expression from calorie-restricted mice was not altered during carcinogenesis. However, SIRT1 expression was increased in mice with poorly differentiated adenocarcinomas and in human prostate cancer cells. Because SIRT1 may function as a tumor promoter, these results suggest that SIRT1 should be considered as a potential therapeutic target for prostate cancer. [Cancer Res 2007;67(14):6612–8]

This article has been cited by other articles:

				N. Kabra, Z. Li, L. Chen, B. Li, X. Zhang, C. Wang, T. Yeatman, D. Coppola, and J. Chen SirT1 Is an Inhibitor of Proliferation and Tumor Formation in Colon Cancer J. Biol. Chem., July 3, 2009; 284(27): 18210 - 18217. [Abstract] [Full Text] [PDF]

				E. J. Cha, S. J. Noh, K. S. Kwon, C. Y. Kim, B.-H. Park, H. S. Park, H. Lee, M. J. Chung, M. J. Kang, D. G. Lee, et al. Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma Clin. Cancer Res., July 1, 2009; 15(13): 4453 - 4459. [Abstract] [Full Text] [PDF]

				T. Liu, P. Y. Liu, and G. M. Marshall The Critical Role of the Class III Histone Deacetylase SIRT1 in Cancer Cancer Res., March 1, 2009; 69(5): 1702 - 1705. [Abstract] [Full Text] [PDF]

				B. Jung-Hynes, M. Nihal, W. Zhong, and N. Ahmad Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer: A TARGET FOR PROSTATE CANCER MANAGEMENT VIA ITS INHIBITION? J. Biol. Chem., February 6, 2009; 284(6): 3823 - 3832. [Abstract] [Full Text] [PDF]

				M. Yamakuchi, M. Ferlito, and C. J. Lowenstein miR-34a repression of SIRT1 regulates apoptosis PNAS, September 9, 2008; 105(36): 13421 - 13426. [Abstract] [Full Text] [PDF]

				T. Ikenoue, K. Inoki, B. Zhao, and K.-L. Guan PTEN Acetylation Modulates Its Interaction with PDZ Domain Cancer Res., September 1, 2008; 68(17): 6908 - 6912. [Abstract] [Full Text] [PDF]

				Correction: SIRT1 and Prostate Cancer Cancer Res., September 1, 2007; 67(17): 8423 - 8423. [Full Text] [PDF]